Logo

Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?

Author(s):
Mohamad Amin PourhoseingholiMohamad Amin Pourhoseingholi1, Sara AshtariSara Ashtari1, Seyed Moayed AlavianSeyed Moayed AlavianSeyed Moayed Alavian ORCID2,*
1Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2Middle East Liver Diseases Center (MELD), Tehran, IR Iran


Hepatitis Monthly:Vol. 14, issue 11; 25540
Published online:Nov 22, 2014
Article type:Editorial
Received:Nov 21, 2014
Accepted:Nov 22, 2014
How to Cite:Mohamad Amin PourhoseingholiSara AshtariSeyed Moayed AlavianSofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?.Hepat Mon.14(11):25540.https://doi.org/10.5812/hepatmon.25540.

Abstract

Full Text

Full text is available in PDF

comments

Leave a comment here


Crossmark
Crossmark
Checking
Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles